BHVN · Biohaven Ltd. · Executive Compensation
$12.97
+0.10 (+0.78%)
At close · Oct 5
Return incl. dividend (before tax)
Market Cap
$2.01B
Shares
151.04M
Volume · Oct 5
1.67M
Avg daily vol (3M)
2.63M
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Vlad Coric | Chief Executive Officer | $10,479,038 |
| Matthew Buten | Chief Financial Officer | $4,043,335 |
| Bruce Car | Chief Scientific Officer | $3,935,078 |
| Kimberly Gentile | Senior Vice President, Clinical Operations | $3,838,971 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Vlad Coric | Chief Executive Officer | $6,819,189 |
| Matthew Buten | Chief Financial Officer | $2,755,637 |
| Bruce Car | Chief Scientific Officer | $2,584,248 |
| Kimberly Gentile | Senior Vice President, Clinical Operations | $2,559,873 |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| Vlad Coric | Chief Executive Officer | $5,971,479 |
| Matthew Buten | Chief Financial Officer | $2,036,473 |
| Bruce Car | Chief Scientific Officer | $1,773,908 |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| John Yetimoglu | director | Appointed | 2026-08-07 |
| Warren Volles | General Counsel and Chief Legal Officer | Appointed | 2026-07-09 |
| David Pirman, Ph.D. | Executive Vice President and Head of Discovery | Appointed | 2026-07-09 |
| Bruce Car, Ph.D. | Chief Innovation Officer | Appointed | 2026-07-09 |
| Matthew Buten | Chief Financial Officer | Appointed | 2022-10-03 |
| Vladimir Coric | Class III director | Appointed | 2022-10-03 |
| Julia Gregory | Class II director | Appointed | 2022-10-03 |
| Kishan Mehta | Class III director | Appointed | 2022-10-03 |
| Gregory Bailey | Class II director | Appointed | 2022-10-03 |
| John Childs | Class II director | Appointed | 2022-10-03 |
| Robert Hugin | Class I director | Appointed | 2022-10-03 |
| Michael T. Heffernan | Class I director | Appointed | 2022-10-03 |
| Irina Antonijevic | Class I director | Appointed | 2022-10-03 |